Nov 29th, 2023
Power your Literature Surveillance with AI-driven Automation
In the highly regulated landscape of pharmacovigilance (PV), ensuring patient safety and health outcomes is paramount. With increasing focus on post-marketing drug surveillance and drug safety, literature monitoring has taken…
Oct 26th, 2023
Unlocking the Potential of Drug Safety Automation for Small and Medium Pharma: People, Process, and System
The pharmaceutical industry is advancing at an unprecedented pace, with new drugs and therapies continually emerging to improve patient outcomes.…
Aug 17th, 2022
AI in Pharmacovigilance: Need, Opportunities and Challenges
Pharmacovigilance is the practice of protecting public health by detecting, assessing, and managing potential adverse […]
Mar 3rd, 2022
The Changing Landscape of Pharmacovigilance Technologies
Modern technology solutions for Pharmacovigilance are required to solve the emerging needs in the area […]
Jan 31st, 2022
An integrated approach to pharmacovigilance
The pharmaceutical market is highly regulated, and any misstep can lead to product recall that […]
Nov 18th, 2021
AI for Drug Safety Case Processing
The Drug Safety and Clinical Data Quality Act is a U.S. law that is meant to provide the FDA with…
Nov 18th, 2021
AI-assisted Literature Monitoring and Review
It is estimated that top pharma companies and research institutions commission around 20 literature review projects each on an average…
Nov 18th, 2021
Understanding Literature Monitoring in Pharmacovigilance – The importance, challenges and role AI can play
The term ‘literature monitoring’ refers to the process by which adverse events or new drug efficacy data are detected in…